General information about Stepworks including our philosophy, beliefs, history, approach, and the people who make Stepworks Stepworks. "Restoring Lives Hurt by Drugs and Alcohol" | Rehabilitation and Detox Center - Call 888-982-1244 for Assistance.
HEALTH is an international journal dedicated to the latest advancement of human health. The goal of this journal is to provide a platform for physicians, health researchers and academics all over the world to promote, share, and discuss various new issues and developments in health related problems. All manuscripts must be prepared in English, and are subject to a rigorous and fair peer-review process.
A commission led by three former Latin American heads of state has called the 30-year U.S. "war on drugs" in Latin America a failure and urged a drastic change in policy.
DrugLib.com is a comprehensive drug database organized by relevance to specific drugs. It provides a convenient, one-stop access to a wide range of information related to your drug of interest, including drug label & prescribing information
ImClone Systems and Bristol-Myers Squibb said yesterday that they would begin to provide their cancer drug, Erbitux, to a limited number of colorectal cancer patients who have exhausted other treatment options.
When does this behavior become inappropriate, causing the patient to be labeled a drug seeker? Clearly, there is no agreement on the definition of drug seeking.
scientists reported that a person's risk of a heart attack is doubled if he or she produces a particular version of FLAP, known more technically as 5-lipoxygenase activating protein. A troublesome variant of this protein boosts production of the inflammat
The re-trial of pain doctor William Hurwitz came to an end in July 2007. The doctor's sentence was reduced to less than five years. He was originally given 25 years.
The anti-inflammatory potential of an oral p38 MAPK inhibitor in humans in vivo suggests that p38 MAPK inhibitors may provide a new therapeutic option in the treatment of inflammatory diseases. Boehringer Ingelheim. 2002 Branger J, et al
Editorial on the "Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial," which studied optimal medical treatment with or without percutaneous coronary intervention (PCI) for stable coronary disease.